Evidence map›Paper›PMID 31641022›Full record

ArticleThe Journal of biological chemistry2019

The cytosolic form of aspartate aminotransferase is required for full activation of TOR complex 1 in fission yeast.

Sophie Reidman, Adiel Cohen, Martin Kupiec, Ronit Weisman

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Mitochondrial aspartate aminotransferase (microPublication biology · 2024
    Article
  3. Article
  4. Article
  5. Endophytic BacteriumFrontiers in microbiology · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sophie ReidmanSchool of Molecular Cell Biology and Biotechnology, Tel Aviv University, Ramat Aviv 69977801, Tel Aviv, Israel.
Adiel CohenDepartment of Natural and Life Sciences, the Open University of Israel, University Road 1, 4353701 Ra'anana, Israel.
Martin KupiecSchool of Molecular Cell Biology and Biotechnology, Tel Aviv University, Ramat Aviv 69977801, Tel Aviv, Israel.
Ronit WeismanDepartment of Natural and Life Sciences, the Open University of Israel, University Road 1, 4353701 Ra'anana, Israel. Electronic address: ronitwe@openu.ac.il.
Open University of Israel · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evolutionarily conserved TOR complex 1 (TORC1) activates cell growth and proliferation in response to nutritional signals. In the fission yeast

Indexed as

MutationArginineAsparagineAspartate AminotransferasesAspartic AcidCytosolGene Expression Regulation, FungalIsoenzymesMechanistic Target of Rapamycin Complex 1Methionine SulfoximineNitrogenSchizosaccharomycesSchizosaccharomyces pombe ProteinsSirolimusArginineAsparagineAspartate AminotransferasesAspartic AcidIsoenzymesMechanistic Target of Rapamycin Complex 1Methionine SulfoximineNitrogenSchizosaccharomyces pombe ProteinsSirolimusaspartate amino acid transferaseCaa1glutamine synthasenitrogen sensingnutrient signalingPsk1S6 kinaseSchizosaccharomyces pombeserine/threonine protein kinasetarget of rapamycin (TOR)TOR complex (TORC)

Identifiers

PMID31641022
PMCPMC6885631
OpenAlexW2981932213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.